Neurology · 1984 · 103 citations · 0 references
MedicineNeurologyPharmacologyMovement DisordersNeuropharmacologyDopaminergic PharmacologyDrug-induced Movement DisordersNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersWithdrawal SyndromesDopamine-related Movement DisordersDopaminergic PathwaysParkinson's Disease PharmacotherapyWithdrawal Dyskinesia
We studied a patient affected with idiopathic Parkinson's disease and levodopa-induced dyskinesias. Fatal hyperpyrexia followed simultaneous levodopa withdrawal and a decrease in the dosage of diphenhydramine. The clinical features were those of the neuroleptic malignant syndrome. The rapid decrease in dopaminergic activity may have been important in causing the syndrome.